D
3.74
0.18 (5.06%)
| Previous Close | 3.56 |
| Open | 3.59 |
| Volume | 694,978 |
| Avg. Volume (3M) | 925,611 |
| Market Cap | 401,459,072 |
| Price / Earnings (Forward) | 16.61 |
| Price / Sales | 1.63 |
| Price / Book | 1.16 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 - 8 Aug 2025 |
| Profit Margin | -206.05% |
| Operating Margin (TTM) | -11.81% |
| Diluted EPS (TTM) | -4.49 |
| Quarterly Revenue Growth (YOY) | -6.80% |
| Total Debt/Equity (MRQ) | 41.43% |
| Current Ratio (MRQ) | 1.75 |
| Operating Cash Flow (TTM) | 67.67 M |
| Levered Free Cash Flow (TTM) | 68.25 M |
| Return on Assets (TTM) | -0.43% |
| Return on Equity (TTM) | -89.99% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Definitive Healthcare Corp. | Bullish | Bearish |
AIStockmoo Score
0.5
| Analyst Consensus | -1.5 |
| Insider Activity | 1.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.50 |
|
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 7.80% |
| % Held by Institutions | 96.96% |
| 52 Weeks Range | ||
| Median | 3.40 (-9.09%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Goldman Sachs | 12 May 2025 | 3.40 (-9.09%) | Hold | 3.58 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 03 Jun 2025 | Announcement | Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) |
| 08 May 2025 | Announcement | Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025 |
| 24 Apr 2025 | Announcement | Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast |
| 04 Apr 2025 | Announcement | Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |